Circulating epigenetic signatures classifying brain insulin resistance in humans
Science Translational Medicine · 2025
DOI: 10.1126/scitranslmed.adv7834 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, 2025. Verfasst von Stephanie Kullmann und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, 72076, Tübingen, Germany. Hauptthemen laut MEDLINE: Insulin Resistance, Epigenesis, Genetic, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 64 Literaturangaben.
Abstract (Originalsprache)
Brain insulin action plays an important role in metabolic and cognitive health, but there is no biomarker available to assess brain insulin resistance in humans. Here, we developed a machine learning framework based on blood DNA methylation profiles of participants who did not have type 2 diabetes with and without brain insulin resistance and detailed metabolic phenotyping. We identified 540 DNA methylation sites (CpGs) as classifiers of brain insulin resistance in a discovery cohort ( n = 167), results that were validated in two replication cohorts ( n = 33 and 24) with high accuracy (83 to 94%). All 540 CpGs were differentially methylated and annotated to 445 genes mapping to neuronal development and axonogenesis processes. Methylation patterns of 98 of 540 CpGs exhibited a strong and significant ( P < 0.05) blood-brain correlation, indicating that blood cells are a reliable proxy to capture brain-specific DNA methylation changes. These blood-based epigenetic signatures could potentially serve in the future for the early detection of individuals with brain insulin resistance in a broad clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, 72076, Tübingen, Germany.
- Department of Internal Medicine, Division of Endocrinology, Diabetology, and Nephrology, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
- German Center for Diabetes Research (DZD), 85764, München-Neuherberg, Germany.
- Department of Experimental Diabetology, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), 14558, Nuthetal, Germany.
- Research Group Epigenetic of Obesity and Diabetes, German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE), 14558, Nuthetal, Germany.
- Division of Endocrinology and Diabetology, Department of Internal Medicine 1, University Hospital Ulm, 89081, Ulm, Germany.
ORCID-Profile: Stephanie Kullmann, Amandeep Singh, Fabian Eichelmann, Markus Jähnert, Svenja Meyhöfer, Hubert Preissl, Matthias B Schulze, Martin Heni, Andreas L Birkenfeld, Meriem Ouni
Zitieren
APA
Kullmann, S., Singh, A., Sehgal, R., Eichelmann, F., Sandforth, L., Wilms, B., Jähnert, M., Peter, A., Meyhöfer, S., Walther, D., Preissl, H., Häring, H. U., Schulze, M. B., Heni, M., Birkenfeld, A. L., Schürmann, A., & Ouni, M. (2025). Circulating epigenetic signatures classifying brain insulin resistance in humans. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.adv7834
Vancouver
Kullmann S, Singh A, Sehgal R, Eichelmann F, Sandforth L, Wilms B, et al. Circulating epigenetic signatures classifying brain insulin resistance in humans. Science Translational Medicine. 2025. doi:10.1126/scitranslmed.adv7834
BibTeX
@article{Kullmann2025,
author = {Kullmann, Stephanie and Singh, Amandeep and Sehgal, Ratika and Eichelmann, Fabian and Sandforth, Leontine and Wilms, Britta and Jähnert, Markus and Peter, Andreas and Meyhöfer, Svenja and Walther, Dirk and Preissl, Hubert and Häring, Hans-Ulrich and Schulze, Matthias B and Heni, Martin and Birkenfeld, Andreas L and Schürmann, Annette and Ouni, Meriem},
title = {Circulating epigenetic signatures classifying brain insulin resistance in humans},
journal = {Science Translational Medicine},
year = {2025},
doi = {10.1126/scitranslmed.adv7834}
}
EUVIMED